-
एलेक्स बोडी और SCANDIC PAY: Mastercard और VISA कार्ड — भुगतान की नई पीढ़ी
-
ALEX BODI och SCANDIC PAY: Mastercard- och VISA-kort – en ny generation betalningar
-
АЛЕКС БОДИ и SCANDIC PAY: карти Mastercard и VISA — ново поколение разплащания
-
알렉스 보디와 SCANDIC PAY: Mastercard·VISA 카드를 통한 차세대 결제
-
أليكس بودي وSCANDIC PAY: بطاقات Mastercard وVISA — جيل جديد من المدفوعات
-
ALEX BODIとSCANDIC PAY:Mastercard・VISAカードによる新世代の決済
-
ALEX BODI 與 SCANDIC PAY:Mastercard 與 VISA 卡——新一代支付方式
-
ALEX BODI a SCANDIC PAY: karty Mastercard a VISA – nová generace plateb
-
ΑΛΕΞ ΜΠΟΝΤΙ και SCANDIC PAY: κάρτες Mastercard και VISA — μια νέα γενιά πληρωμών
-
ALEX BODI i SCANDIC PAY: karty Mastercard i VISA — nowa generacja płatności
-
АЛЕКС БОДІ та SCANDIC PAY: картки Mastercard і VISA — нове покоління платежів
-
АЛЕКС БОДИ и SCANDIC PAY: карты Mastercard и VISA — новое поколение платежей
-
ALEX BODI and SCANDIC PAY: Mastercard and VISA Cards – A New Generation of Payments
-
ALEX BODI și SCANDIC PAY: Cardurile Mastercard și VISA – o nouă generație de plăți
-
AI Bots and Plagiarism: How Philadelphia and New Jersey News Sites Are Using Fake Content
-
UK House Prices Fall 1.2% as London Records Sharpest Annual Decline
-
The Dice Box Recommends Winter Board Games for Sneinton Market Lounge
-
Get Huge: Looksmaxxing to Death Docuseries Details Tony Huge's Thailand Crimes
-
Government Overspends €607 Million on International Protection Accommodation in 2024
-
IIM Indore Announces IPMAT 2027 Exam Date for April 24
-
Palestinians Salvage Cultural Heritage from Gaza Rubble Amid Widespread Destruction
-
Quick Pressure-Cooker Beef Stew and Rice Minestrone Soup Recipes
-
PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
-
Ethur Takes On Hiring Fraud With Facial Biometrics Identity Checks and Connected Payroll and Bank Data
-
NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
-
Route1 Announces 2026 Annual Meeting Results
-
Healixa's FrostPulse(TM) Technology Solves a Major Roadblock to Data Center Growth: Cooling Without the Water Burden
-
Protagenic Therapeutics Announces Private Placement of Up to $5 Million to Advance PT00114 into Its First U.S. Clinical Trial in Generalized Anxiety Disorder
-
Patriot Software Adds Performance Reviews to Patriot HR
-
5E Advanced Materials to Host Fiscal First Quarter 2027 Earnings Conference Call on November 17, 2026
-
Marketing Worldwide Corporation (OTC:MWWC) Announces 1-for-350 Reverse Stock Split Effective November 11, 2026
-
TAMKO and Kansas City Chiefs Announce 2026 Operation Rooftop Recipient
-
Healthcare Leaders Identify Priorities for Agentic AI Adoption in 2027-2028 - Black Book
-
Aptevo Therapeutics Announces Exercise of Existing Warrants for $3.0 Million Gross Proceeds
-
Arrive AI Announces Strategic Investment in Ottonomy to Accelerate Autonomous Delivery Network Expansion
-
6 Pieces of Furniture Worth Investing In
-
LiveOne (Nasdaq: LVO) to Report Second Quarter Fiscal 2027 Financial Results on November 12, 2026
-
Green Leaf Innovations (OTC: GRLF) Meets OTCID Disclosure Requirements Following Profitable Q2 2026 Results
-
Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird's National Security Conference
-
XCF Global Hosts USDA at New Rise Renewables Reno as Facility Surpasses 4.4 Million Gallons Since Restart
-
Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
-
AmeriLife Welcomes Finance Veteran Richard Dziadzio as Chief Financial Officer; Names Jim Quinn President & Chief Transformation Officer
-
Trifecta Gold Reports 2026 Exploration Results from the Liam and Lois Projects, Tombstone Gold Belt, Yukon
-
Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
-
NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Christmas Day Shifts More than Double as Americans Return to In-Person Holiday Celebrations
-
THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
-
Fulcrum Metals PLC Announces Publication of Updated Investor Presentation
-
Guardian Metal Resources PLC Announces Proposed Spin-Out of Non-Tungsten Projects
Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office
Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announced the filing of two patents to protect its groundbreaking delivery systems. These patents are set to revolutionize the company's product lines and enhance the proprietary transport of SOD and other powerful ingredients throughout the body to enhance wellness, and promote health and anti aging from cellular levels.
Advancing Supplement Technology
The patent-pending formulations represent a significant leap forward in supplement technology worldwide. Cellev8's delivery mechanisms have proven effect with thousands of people by focusing on reducing oxidative stress and providing superior cellular protection in the body. Cellev8 revolutionizes supplement effectiveness by employing advanced delivery mechanisms to enhance SOD absorption and combining it with powerful, targeted ingredients. This innovative approach maximizes the potency and precision of their products, delivering optimal benefits to specific areas of the body. These innovations are expected to further solidify the company's position as a leader in the wellness industry.
Key Highlights of the Patent Filings:
• Enhanced Ingredient Delivery: The new systems are designed to improve the absorption and utilization of key ingredients, including the company's flagship SOD formulations.
• Proprietary Transport Mechanisms: Cellev8's unique approach ensures that active compounds reach their intended targets more efficiently within the body.
• Broad Application: The patents cover delivery systems applicable across Cellev8's entire product range, including their popular inflammation and recovery gummies.
Impact on Product Lines
Michael Ferraro, CEO of Cellev8 Nutrition, commented on the patent filings: "These patents represent a culmination of our research and development efforts. They will not only protect our intellectual property but also pave the way for more effective and innovative wellness solutions for our customers. Imagine supplements that not only deliver powerful key ingredients more efficiently but also provides a precisely tailored blend of nutrients and critical anti-oxidants to support your body's unique needs. That's the Cellev8 difference! With our innovative approach, we're not just creating supplements - we're crafting personalized solutions for optimal health and vitality.."
The new delivery systems are expected to enhance the performance of Cellev8's existing products, including:
• Inflammation & Recovery Gummies
• Focus & Memory Gummies
• GLP1 Support Gummies
Future Prospects
With these patent filings, Cellev8 Nutrition is poised to expand its market presence with a lineup of additional products and potentially collaborate with larger nutraceutical and pharmaceutical companies interested in leveraging the benefits of their enhanced delivery process.
The company continues to focus on developing cutting-edge wellness products that promote health and vitality, serving thousands of customers, including over 40 professional and collegiate athletic teams, clients of FDA certified Zyppah products and patients/clients of publicly traded FDA approved sleep apnea company Vivos Therapeutics Inc.
For more information about Cellev8 Nutrition Inc and its innovative product line, visit www.cellev8.com
W.Nelson--AT